The treatment of primary focal segmental glomerulosclerosis

Renal Failure

Volumn 22, Issue 6, 2000, Pages 685-696

  Korbet, S M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOTOXIC AGENT; STEROID;

CONFERENCE PAPER; GLOMERULOSCLEROSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REMISSION; SURVIVAL;

ANTI-INFLAMMATORY AGENTS; DISEASE PROGRESSION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; PREDNISONE; PROGNOSIS; RECURRENCE;

EID: 0033727985     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100101956     Document Type: Conference Paper

References (50)

1. The primary nephrotic syndrome of childhood: Classification and clinicopathologic study of 406 cases
2. International Study of Kidney Disease in Children: The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone
3. Focal glomerulosclerosis: Natural history and treatment
4. The racial prevalence of glomerular lesions in nephrotic adults
5. Increasing incidence of focalsegmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study
6. The enigma of focal segmental glomerulosclerosis
7. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997
8. Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study
9. Racial differences in the prevalence and presentation of glomerular disease in adults
10. Primary focal segmental glomerulosclerosis
11. Recurrent focal sclerosis after renal transplantation
12. Focal glomerular sclerosis: Contrasting clinical patterns in children and adults
13. Evidence suggesting undertreatment in adults with idiopathic focal segmental glomerulosclerosis
14. The longterm prognosis of patients with focal segmental glomerulosclerosis
15. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis
16. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy
17. Focal segmental glomerular sclerosis in adults: Presentation, course and response to treatment
18. Primary Focal Segmental Glomerulosclerosis
19. Focal segmental glomerulosclerosis with rapid decline in renal function ('malignant FSGS')
20. The prognosis of focal segmental glomerular sclerosis of adulthood
21. Longterm prognosis of focal sclerosing glomerulonephritis: An analysis of 250 cases with particular regard to tubulointerstitial changes
22. The cellular lesion of focal segmental glomerulosclerosis: Therapeutic response and prognosis
23. Primary focal segmental glomerular sclerosis in adults: Prognostic value of histologic variants
24. Focal segmental glomerulosclerosis with and without nephrotic syndrome in children
25. Further studies on the glomerular tip lesion: Early and late stages and life table analysis
26. Primary focal segmental glomerulosclerosis: Pathology, histologic variants, and pathogenesis
27. Collapsing gloemerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis
28. The impact of prolonged immunosuppression on the outcome of idiopathic focalsegmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study
29. Adult lipoid nephrosis: Clinicopathological correlations
30. Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis
31. Idiopathic adult focal segmental glomerulosclerosis: A clinicopathological study and response to steroid
32. The Collaborative Group of the Societe De Nephrologie D: Longterm renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome
33. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly
34. Longterm outcome in children and adults with classic focal segmental glomerulosclerosis
35. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: Minimal change disease and focal segmental glomerulosclerosis
36. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis: A report of the International Study of Kidney Disease in Children
37. Treatment of nephrotic syndrome with cyclosporin A. What remains in 1994?
38. A randomized trial of cyclosporine in steroid resistant idiopathic nephrotic syndrome
39. Follow up results from a randomized controlled trial of cyclosporine vs placebo in adults with steroid resistant idiopathic focal segmental glomerulosclerosis
40. Results of a 6 month randomized controlled trial of cyclosporine vs placebo in adults with steroid resistant idiopathic focal segmental glomerulosclerosis
41. A randomized doubleblind placebocontrolled trial of cyclosporine in steroidresistant idiopathic focal segmental glomerulosclerosis in children
42. Longterm benificial effects of angiotensinconverting enzyme inhibition in patients with nephrotic proteinuria
43. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy
44. Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function
45. Effect of the angiotensinconvertingenzyme inhibitor benazepril on the progression of chronic renal insufficiency
46. Effect of plasma protein adsorption on protein excretion in kidneytransplant recipients with recurrent nephrotic syndrome
47. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis
48. Plasmapheresis in the treatment of steroidresistant focal segmental glomerulosclerosis in native kidneys
49. Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis
50. Adding plasmapheresis to corticosteroids and alkylating agents: Does it benefit patients with focal segmental glomerulosclerosis?